Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-030284

Chief Executive Officer gave up 2,646 shares (to pay taxes)

  • Chief Executive Officer acquired 8,726 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2025-09-30 Option exercise +8,726 82,198 D
Robinson Chandler Chief Executive Officer 2025-09-30 Shares withheld for taxes −2,646 $81.67 $216,099 79,552 D
Derivatives
Robinson Chandler Chief Executive Officer 2025-09-30 Option exercise · Restricted Stock Units −8,726 72,599 D
Loading xslF345X05/rdgdoc.xml…